Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chi-Ping Huang

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
BMC Urology|September 12, 2020
External validation of the Simplified PADUA REnal (SPARE) nephrometry system in predicting surgical outcomes after partial nephrectomyChi-Ping Huang, Chao-Hsiang Chang, Hsi-Chin Wu, et al.
Scientific Reports|October 1, 2016
Proteome Profiling of Urinary Exosomes Identifies Alpha 1-Antitrypsin and H2B1K as Diagnostic and Prognostic Biomarkers for Urothelial CarcinomaShih-Yi Lin, Chao-Hsiang Chang, His-Chin Wu, et al.
The Kaohsiung Journal of Medical Sciences|June 26, 2012
The impact of gender and size on the pathology of small renal massPo-Fan Hsieh, Chao-Hsiang Chang, Chi-Ping Huang, et al.
Lower Urinary Tract Symptoms|May 16, 2023
Mirabegron is better tolerated than solifenacin in Sjogren's syndrome patients with overactive bladder symptoms-A randomized controlled trialHao Xiang Chen, Shih-Hsin Chang, Der-Yuan Chen, et al.
Nature Communications|June 3, 2020
The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancerKeliang Wang, Jie Luo, Shuyuan Yeh, et al.
International Journal of Cancer|June 26, 2024
Real-world safety and effectiveness of radium-223 in patients with metastatic castration-resistant prostate cancer: Interim analyses of the prospective, observational RAPIT studyChao-Yuan Huang, Chi-Ping Huang, Yu-Yi Huang, et al.
BMC Urology|April 29, 2022
A comparative study of transperineal software-assisted magnetic resonance/ultrasound fusion biopsy and transrectal cognitive fusion biopsy of the prostatePo-Fan Hsieh, Tian-You Chang, Wei-Ching Lin, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|April 12, 2025
Real-world study of cabozantinib treatment of advanced renal cell carcinoma in TaiwanYu-Chieh Tsai, Jian-Ri Li, Kun-Yuan Chiu, et al.
Aging|September 13, 2020
Preclinical studies show using enzalutamide is less effective in docetaxel-pretreated than in docetaxel-naïve prostate cancer cellsChangyi Lin, Fu-Ju Chou, Jieyang Lu, et al.
The Kaohsiung Journal of Medical Sciences|July 26, 2018
Prostate Health Index (PHI) improves prostate cancer detection at initial biopsy in Taiwanese men with PSA 4-10 ng/mLPo-Fan Hsieh, Chao-Hsiang Chang, Chi-Rei Yang, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
BMC Urology|September 12, 2020
External validation of the Simplified PADUA REnal (SPARE) nephrometry system in predicting surgical outcomes after partial nephrectomyChi-Ping Huang, Chao-Hsiang Chang, Hsi-Chin Wu, et al.
Scientific Reports|October 1, 2016
Proteome Profiling of Urinary Exosomes Identifies Alpha 1-Antitrypsin and H2B1K as Diagnostic and Prognostic Biomarkers for Urothelial CarcinomaShih-Yi Lin, Chao-Hsiang Chang, His-Chin Wu, et al.
The Kaohsiung Journal of Medical Sciences|June 26, 2012
The impact of gender and size on the pathology of small renal massPo-Fan Hsieh, Chao-Hsiang Chang, Chi-Ping Huang, et al.
Lower Urinary Tract Symptoms|May 16, 2023
Mirabegron is better tolerated than solifenacin in Sjogren's syndrome patients with overactive bladder symptoms-A randomized controlled trialHao Xiang Chen, Shih-Hsin Chang, Der-Yuan Chen, et al.
Nature Communications|June 3, 2020
The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancerKeliang Wang, Jie Luo, Shuyuan Yeh, et al.
International Journal of Cancer|June 26, 2024
Real-world safety and effectiveness of radium-223 in patients with metastatic castration-resistant prostate cancer: Interim analyses of the prospective, observational RAPIT studyChao-Yuan Huang, Chi-Ping Huang, Yu-Yi Huang, et al.
BMC Urology|April 29, 2022
A comparative study of transperineal software-assisted magnetic resonance/ultrasound fusion biopsy and transrectal cognitive fusion biopsy of the prostatePo-Fan Hsieh, Tian-You Chang, Wei-Ching Lin, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|April 12, 2025
Real-world study of cabozantinib treatment of advanced renal cell carcinoma in TaiwanYu-Chieh Tsai, Jian-Ri Li, Kun-Yuan Chiu, et al.
Aging|September 13, 2020
Preclinical studies show using enzalutamide is less effective in docetaxel-pretreated than in docetaxel-naïve prostate cancer cellsChangyi Lin, Fu-Ju Chou, Jieyang Lu, et al.
The Kaohsiung Journal of Medical Sciences|July 26, 2018
Prostate Health Index (PHI) improves prostate cancer detection at initial biopsy in Taiwanese men with PSA 4-10 ng/mLPo-Fan Hsieh, Chao-Hsiang Chang, Chi-Rei Yang, et al.
Pageof 10